Moreover, we found that Dot1l copies had some mutations in ccRCC samples from the DNA information of 2013 TCGA cohort data, which indicated that Dot1l might be associated with ccRCC. This evidence concerns the gene DOT1L and nonpapillary renal cell carcinoma.